Research groups
Websites
-
OCTRU
OCTRU hub
-
Experimental Medicine & Rheumatology
Experimental Medicine & Rheumatology
Anne Francis
D.Phil
Clinical Trial Operational Lead – Experimental Medicine and Rheumatology
As Clinical Trial Operational Lead I am responsible for overseeing a growing portfolio of studies in experimental medicine and rheumatology (EMR) from inception to close out and archiving. I advise on and contribute to new research proposals, funding applications, and study protocols. Once studies are funded I oversee and support the work of the trial management team, providing advice on compliance with SOPs, relevant guidelines and regulations, with most studies running as part of the OCTRU portfolio.
I have over 14 years’ experience of working in clinical research. Prior to my current role I have managed a number of Investigator-led clinical trials in oncology and rheumatology. These include both CTIMPs and non-CTIMPs, covering phase 1 to 3, protocol development to analysis and close-out. I have also worked as a Clinical Trial Monitor and in trial administration.
My background and training is as a scientist, with a D.Phil in Plant Genetics from the University of Oxford and a BSc (Hons) in Biochemistry & Genetics (Cert Ind) from the University of Leeds.
If you are designing a new research study within experimental medicine and rheumatology please get in touch to benefit from the input of the experienced research team with EMR and OCTRU.
ORCID 0000-0003-4618-774X
Recent publications
-
Journal article
Hopewell S. et al, (2024), BMJ Open, 14
-
The protocol of a clinical effectiveness trial comparing standard step up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomised controlled trial
Journal article
WATSON M. et al, (2024), Therapeutic Advances in Musculoskeletal Disease
-
Journal article
Abhishek A. et al, (2024), Lancet Rheumatol, 6, e92 - e104
-
Journal article
Barber VS. et al, (2023), BMJ Open, 13
-
Optimising Psoriatic Arthritis Therapy with Immunological Methods to Increase Standard Evaluation: The protocol of an open-label multi-centre, parallel-group, two arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.
Journal article
RICHARDS D., (2023), BMJ Open